July 16, 2020 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans) (Paris:ALIMP), a medical technology company specializing in vertebral and knee-surgery implants, today announces that its JAZZ Cap® technology has been patented in Japan. Ludovic Lastennet, CEO of IMPLANET, commented: “Japan represents the world’s third largest …